Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Shortage reports
Actual shortage:
214 (7%)
Anticipated shortage:
0 (0%)
Avoided shortage:
10 (0%)
Resolved:
2706 (92%)
2930
Discontinuation Reports
To be discontinued:
2 (1%)
Discontinued:
298 (99%)
Reversed:
0 (0%)
300
363 (11%)
99 (46%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2024-02-08 | 2024-04-18 | 218974 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2024-03-18 | 2024-04-11 | 222566 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-04-10 | 2020-10-22 | 111838 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-01-12 | 2023-01-19 | 180881 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2020-08-06 | 2021-01-07 | 121852 |
| ACT QUETIAPINE | 200MG | TABLET | Resolved | 2020-08-27 | 2020-09-17 | 123078 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2020-09-24 | 2020-10-01 | 124918 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-05 | 2020-09-18 | 93166 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-09-19 | 2020-07-10 | 94384 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2019-10-10 | 2020-03-05 | 96079 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2021-03-04 | 2021-04-21 | 135129 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2023-06-26 | 2023-07-12 | 196367 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-18 | 2023-10-05 | 199106 |
| ACT QUETIAPINE | 100MG | TABLET | Resolved | 2023-07-20 | 2023-10-06 | 199390 |
| ACT QUETIAPINE | 25MG | TABLET | Resolved | 2022-07-25 | 2023-01-19 | 165453 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-04-27 | 2023-08-18 | 190734 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2022-03-04 | 2022-04-21 | 156058 |
| ACT RALOXIFENE | 60MG | TABLET | Actual shortage | 2025-05-02 | 2025-05-02 | 256459 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2023-06-20 | 2023-07-05 | 195781 |
| ACT RALOXIFENE | 60MG | TABLET | Resolved | 2020-10-15 | 2020-12-03 | 126516 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65017 |
| TEVA-TRIMEL | 400MG 80MG | TABLET | Discontinued | 2020-02-13 | 2020-02-13 | 106133 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65020 |
| TEVA-TRIMEL DS | 800MG 160MG | TABLET | Discontinued | 2018-10-19 | 2018-10-19 | 65023 |
| TEVA-VALSARTAN | 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256155 |
| TEVA-VALSARTAN | 160MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256152 |
| TEVA-VALSARTAN | 80MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256149 |
| TEVA-VALSARTAN | 40MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256146 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255830 |
| TEVA-VALSARTAN/HCTZ | 25MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256143 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 320MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256140 |
| TEVA-VALSARTAN/HCTZ | 25MG 160MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255833 |
| TEVA-VALSARTAN/HCTZ | 12.5MG 80MG | TABLET | Discontinued | 2025-04-25 | 2025-04-25 | 255827 |
| TEVA-VENLAFAXINE XR | 75MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-02-07 | 2020-02-08 | 105537 |
| TEVA-VENLAFAXINE XR | 37.5MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-06-11 | 2020-06-11 | 117546 |
| TEVA-VENLAFAXINE XR | 150MG | CAPSULE (EXTENDED RELEASE) | Discontinued | 2020-09-24 | 2020-09-24 | 124899 |
| TEVA-VORICONAZOLE | 200MG | TABLET | Discontinued | 2025-04-29 | 2025-04-29 | 256166 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-09-27 | 2019-10-01 | 94980 |
| VINORELBINE TARTRATE FOR INJECTION | 10MG | SOLUTION | Discontinued | 2019-10-17 | 2019-10-17 | 96695 |
| ZOLEDRONIC ACID INJECTION | 5MG | SOLUTION | Discontinued | 2017-06-27 | 2017-06-27 | 14030 |